Ultrasonic Mist Inhaler

The ultrasonic mist inhaler addresses leakage and inconsistent dosing in conventional vaporizing inhalers by using ultrasonic vibrations to create a mist, ensuring consistent delivery and a safer, compact design.

JP7578712B2Active Publication Date: 2024-11-06SHAHEEN INNOVATIONS HLDG LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2022561689
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2019-12-15
Publication Date
2024-11-06
Estimated Expiration
2039-12-15

AI Technical Summary

Technical Problem

Conventional electronic vaporizing inhalers suffer from leakage issues, inconsistent dosing, and the risk of burning metal components, which complicates their design and user experience.

Method used

An ultrasonic mist inhaler that combines a liquid reservoir and sonication chamber, using ultrasonic vibrations to create a mist without heating, thereby eliminating the need for a heating element and reducing the risk of leakage and inconsistent dosing.

Benefits of technology

The ultrasonic mist inhaler effectively produces a consistent mist without heating, preventing liquid leakage and metal burning, while offering a compact and user-friendly design.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578712000001
    Figure 0007578712000001
  • Figure 0007578712000002
    Figure 0007578712000002
  • Figure 0007578712000003
    Figure 0007578712000003
Patent Text Reader

Abstract

The present invention relates to an ultrasonic mist inhaler (100) comprising a mouthpiece (1) for inhaling mist, a liquid reservoir structure (2) including a liquid chamber (21) adapted to receive the liquid to be misted, and an ultrasonic treatment chamber (22) in fluid communication with the liquid chamber (21), wherein at least a portion of the liquid reservoir structure (2) and the mouthpiece (1) form the ultrasonic treatment chamber (22).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to an ultrasonic mist inhaler that converts liquid into mist by ultrasonic vibration. [Background technology]

[0002] Electronic vaporizers have become popular among smokers who want to satisfy their nicotine cravings while avoiding the harsh chemicals, such as tar, found in traditional cigarettes. Electronic vaporizers may contain liquid nicotine, usually mixed with nicotine oil, solvents, water, and often flavorings. When a user draws on the electronic vaporizer, the liquid nicotine is drawn into the vaporizer, where it is heated into a vapor. When the user draws on the electronic vaporizer, the vapor containing the nicotine is inhaled. Such electronic vaporizers may have medical purposes.

[0003] Electronic vaporizers and other vapor inhalers typically have a similar design. Most electronic vaporizers have a liquid nicotine reservoir with an inner membrane, typically cotton, such as a capillary element that holds the liquid nicotine so as to prevent leakage from the reservoir. Nevertheless, these cigarettes are still prone to leakage because there is no obstruction to prevent the liquid from flowing out of the membrane and into the mouthpiece. Leaking electronic vaporizers is problematic for several reasons. First, liquid can leak into the electronic components and cause serious damage to the device. Second, liquid can leak into the mouthpiece of the electronic vaporizer, causing the user to inhale unvaporized liquid.

[0004] Electronic vaporizers are also known to provide inconsistent doses between puffs. The aforementioned leaks are one of the reasons for inconsistent dosing, as the membrane can become oversaturated or undersaturated near the vaporizer. If the membrane is oversaturated, the user may experience a stronger vapor than the desired dose, and if the membrane is undersaturated, the user may experience a weaker vapor than the desired dose. A slight change in the strength of the user's puff can result in a stronger or weaker dose. Inconsistent dosing, along with leaks, can lead to a faster consumption of the vaporizing liquid.

[0005] Furthermore, conventional electronic vaporizers tend to rely on high temperature induction of a metal heating element configured to heat the liquid within the electronic cigarette, thus vaporizing the liquid that can be inhaled. Problems with conventional electronic vaporizers include the possibility of the metal burning and the subsequent inhalation of the metal along with the burnt liquid. Also, some people do not like the burnt smell of the heated liquid.

[0006] Electronic vaporizer inhalers are generally designed such that the liquid nicotine reservoir is located away from the metal heating components so as not to heat the unused liquid in the reservoir, which makes the inhalation device cumbersome and more complicated to manufacture.

[0007] Thus, there is a need in the art for an electronic vaporizer inhaler that is better able to tolerate these drawbacks. Summary of the Invention

[0008] According to one aspect of the present invention, an ultrasonic mist inhaler comprises: - A mouthpiece for inhaling the mist; - a liquid reservoir structure comprising a liquid chamber adapted to receive the liquid to be misted; - an ultrasonic treatment chamber in fluid communication with the liquid chamber; At least a portion of the liquid reservoir structure and the mouthpiece form the ultrasonic treatment chamber.

[0009] The arrangement of the mouthpiece and sonication chamber makes the ultrasonic mist inhaler more compact.

[0010] By using an ultrasonic vibration chamber for ultrasonic vibration in the ultrasonic mist inhaler, the liquid chamber and the ultrasonic vibration chamber can be combined into a liquid reservoir structure.

[0011] It should be noted that the expression "mist" as used in the present invention means that the liquid is not heated as is usually done in conventional inhalers known from the prior art, which in fact use a heating element to heat the liquid above its boiling temperature to generate vapour, which is different from a mist.

[0012] Indeed, when sonicating a liquid at high intensity, the sound waves propagating through the liquid medium undergo alternating high-pressure (compression) and low-pressure (dilution) cycles at different speeds depending on the frequency. During the low-pressure cycle, the high-intensity ultrasound creates small vacuum bubbles or voids in the liquid. When these bubbles reach a volume where they cannot absorb the energy, they collapse violently during the high-pressure cycle. This phenomenon is called cavitation. Extremely high local pressures are then generated. In cavitation, broken capillary waves are generated, breaking the surface tension of the liquid and tiny droplets are rapidly released into the air as a mist.

[0013] In an ultrasonic mist inhaler, the liquid reservoir structure may comprise an inhalation channel that provides an air passage from the sonication chamber to the surroundings.

[0014] In an ultrasonic mist inhaler, the inhalation passage may consist of a frusto-conical element disposed between the mouthpiece and the liquid reservoir structure.

[0015] In an ultrasonic mist inhaler, the inhalation channel may consist of an internal container that separates the sonication chamber and the liquid chamber.

[0016] In the ultrasonic mist inhaler, the inner container may form the inner wall of the liquid chamber.

[0017] In the ultrasonic mist inhaler, the frusto-conical element may be in contact with the inner container.

[0018] In the ultrasonic mist inhaler, the mouthpiece may include an internal duct that receives the frusto-conical element.

[0019] In the ultrasonic mist inhaler, the liquid reservoir structure may include an outer container that defines an outer wall of the liquid chamber.

[0020] In an ultrasonic mist inhaler, a capillary element may be disposed between the liquid chamber and the sonication chamber.

[0021] In the ultrasonic mist inhaler, the inner container may comprise a first section and a second section in which the capillary element is disposed.

[0022] The capillary element may be a gauze. The capillary element may be made of bamboo fiber, preferably 100% bamboo fiber, or of cotton, silica, tobacco cotton, or any combination thereof.

[0023] In the ultrasonic mist inhaler, the capillary element may have a flat shape extending between the sonication chamber and the liquid chamber.

[0024] In the ultrasonic mist inhaler, the capillary element may comprise a central portion and a peripheral portion.

[0025] In the ultrasonic mist inhaler, the peripheral portion may have an L-shaped cross section that extends to the liquid chamber.

[0026] In the ultrasonic mist inhaler, the central portion may have a U-shaped cross section that extends to the sonication chamber.

[0027] In the ultrasonic mist inhaler, the liquid reservoir structure may comprise an airflow member for supplying airflow from the surroundings to the ultrasonic treatment chamber.

[0028] In the ultrasonic mist inhaler, the airflow member comprises an airflow bridge and an airflow duct, the airflow bridge having at least an airway opening and forming part of an inhalation channel, and the airflow duct extending from the airflow bridge into the ultrasonic treatment chamber for providing airflow from the surroundings to the ultrasonic treatment chamber.

[0029] The airflow bridge preferably comprises two semi-circular airway openings.

[0030] The airflow bridge preferably engages the frusto-conical element.

[0031] In the ultrasonic mist inhaler, the airflow duct may be fronted by a capillary element.

[0032] In the ultrasonic mist inhaler, the airflow bridge may comprise at least a peripheral opening that provides airflow to the airflow duct.

[0033] In the ultrasonic mist inhaler, the frusto-conical element may comprise at least a peripheral opening aligned with the peripheral opening of the airflow bridge.

[0034] In the ultrasonic mist inhaler, the mouthpiece may comprise at least a peripheral opening aligned with the peripheral opening of the airflow bridge and the peripheral opening of the frusto-conical element.

[0035] In the ultrasonic mist inhaler, an airflow chamber may be disposed between the mouthpiece and the frusto-conical element.

[0036] More precisely, the end of the airflow duct extends within the ultrasonic treatment chamber and may be adjacent to or at the capillary element.

[0037] In the ultrasonic mist inhaler, the airflow bridge and the airflow duct may be made integrally.

[0038] In the ultrasonic mist inhaler, the means for ultrasonic vibration may consist of a means for ultrasonic vibration.

[0039] The expression "ultrasonic vibration means" is similar to the expression "ultrasonic oscillation component" used in patent application PCT / IB2019 / 055192.

[0040] In an ultrasonic mist inhaler, the ultrasonic vibration means is supported by an elastic member.

[0041] The elastic member is formed from an annular plate of rubber.

[0042] The resilient member has an internal bore with grooves designed therein for maintaining a means of ultrasonic vibration.

[0043] In this case, since the elastic member is in line contact with the ultrasonic vibration means, it is possible to more effectively prevent the vibration of the liquid reservoir structure from being suppressed, and therefore the fine particles of the liquid misted by the mist generating member can be sprayed over a greater distance.

[0044] In an ultrasonic mist inhaler, a high frequency voltage is applied to the ultrasonic vibration means to cause the ultrasonic vibration means to ultrasonically vibrate, thereby turning a liquid supplied to a part of the ultrasonic vibration means into mist and spraying it.

[0045] According to such an ultrasonic mist inhaler, fine particles of liquid that have been converted into mist by means of ultrasonic vibrations having a relatively small size can be sprayed far away.

[0046] The ultrasonic vibration means may be a transducer, preferentially designed in the shape of a circular plate, the material of the piezoelectric transducer being preferably ceramic.

[0047] In the ultrasonic mist inhaler, the U-shaped cross section has an inner portion and an outer portion, and the inner portion of the U-shaped cross section may be in surface contact with the ultrasonic vibration means, and the outer portion of the U-shaped cross section may not be in surface contact with the ultrasonic vibration means.

[0048] In the ultrasonic mist inhaler, the outer portion of the U-shaped cross section may be formed with a ventilation opening through which the mist generated between the outer portion of the U-shaped cross section and the ultrasonic vibration means can pass.

[0049] In the ultrasonic mist inhaler, the inner container may be configured to receive a mechanical spring.

[0050] Preferably, a mechanical spring presses the central portion of the capillary element against the means of ultrasonic vibration to ensure surface contact.

[0051] In the ultrasonic mist inhaler, the ultrasonic treatment chamber may have a bottom plate that closes the ultrasonic treatment chamber.

[0052] In the ultrasonic mist inhaler, the base plate may be configured to support the elastic member.

[0053] In the ultrasonic mist inhaler, the bottom plate may have an upper surface having a recess in which the elastic member can be received.

[0054] In the ultrasonic mist inhaler, the liquid chamber may have an upper surface representing the maximum level of the liquid chamber and a lower surface representing the minimum level of the liquid, the lower surface being the upper surface 5 of the base plate.

[0055] In the ultrasonic mist inhaler of the present invention, the liquid reservoir structure may comprise a cap that closes the liquid chamber.

[0056] In the ultrasonic mist inhaler, the cap may have a lower surface, and the upper surface of the liquid chamber is the lower surface of the cap.

[0057] In the ultrasonic mist inhaler, the base plate may be arranged to receive a connector for supplying power to the means of ultrasonic vibration.

[0058] The ultrasonic mist inhaler includes a first connector and a second connector, the first connector being a spring-loaded contact probe and the second connector being a side pin across an elastic member, the spring-loaded contact probe achieving permanent contact with the ultrasonic vibration means.

[0059] Preferably, the metal plate ensures electrical contact between the second connector and the means of ultrasonic vibration.

[0060] In the ultrasonic mist inhaler, the liquid reservoir structure may have an upper end that is fluidly coupled to the internal bore and includes an airway configured to allow liquid mist to flow out of the airway.

[0061] In an ultrasonic mist inhaler, a liquid reservoir structure may be located between the mouthpiece and a casing that houses electrical components for powering and operating the inhaler.

[0062] The bottom plate is sealed to prevent leakage of liquid from the sonication chamber into the casing.

[0063] In the ultrasonic mist inhaler, the upper end of the liquid reservoir structure may be coupled to a mouthpiece via a frusto-conical element, the mouthpiece being configured to allow inhalation of the liquid mist that flows out of the airways into the surroundings.

[0064] Advantageously, the liquid reservoir structure is removable from the mouthpiece and the casing.

[0065] The liquid reservoir structure and the mouthpiece or casing may include complementary arrangements for engaging with each other, further such complementary arrangements may include any of a bayonet type arrangement, a threaded engagement arrangement, a magnetic arrangement and a friction fit arrangement, wherein the liquid reservoir structure includes a portion of the arrangement and the mouthpiece 1 or casing includes a complementary portion of the arrangement.

[0066] Such a design allows the liquid reservoir structure to be disposable: it can be removed and re-installed when needed. This feature gives the user the freedom to change flavors without the restriction of having to use the entire flavor or discard the unused liquid.

[0067] Furthermore, such a design eliminates the risk of fatigue of the ultrasonic vibration means within the sonication chamber, having a disposable ultrasonic vibration means preventing the risk of fatigue and a disposable capillary element preventing the risk of flavor mixing.

[0068] In the ultrasonic mist inhaler, the integrated circuit may be coupled to the lower end of the liquid reservoir structure and communicatively coupled to the means of ultrasonic vibration, the integrated circuit being configured to vibrate the means of ultrasonic vibration.

[0069] Preferably, the ultrasonic vibration means is in electrical communication with the integrated circuit via the connector.

[0070] Advantageously, the integrated circuit is designed to convert a direct current into a high frequency alternating current.

[0071] The ultrasonic vibration means may be powered from the electrical components of the casing via a connector.

[0072] The casing is preferably configured to contain the electrical storage device and may enclose at least a portion of the integrated circuit.

[0073] The casing may have all the features described in patent application PCT / IB2019 / 055192.

[0074] In the ultrasonic mist inhaler of the present invention, the liquid received in the liquid chamber contains 57 to 70% (w / w) vegetable glycerin and 30 to 43% (w / w) propylene glycol, and the propylene glycol contains nicotine and flavoring.

[0075] An ultrasonic mist inhaler or personal ultrasonic misting device: a liquid reservoir structure including a liquid chamber or cartridge adapted to receive the liquid to be atomized; - an ultrasonic treatment chamber in fluid communication with the liquid chamber or cartridge; The liquid received in the liquid chamber comprises 57-70% (w / w) vegetable glycerin and 30-43% (w / w) propylene glycol, the propylene glycol including nicotine and flavoring.

[0076] Some embodiments are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings. [Brief description of the drawings]

[0077] [Figure 1] FIG. 1 is an exploded perspective view showing components of an ultrasonic mist inhaler according to an embodiment of the present invention. [Diagram 2] FIG. 2 is an exploded perspective view of components of an inhaler liquid reservoir structure according to an embodiment of the invention. [Diagram 3] FIG. 3 is a cross-sectional view of components of the inhaler liquid reservoir structure according to FIG. [Figure 4A] FIG. 4A is an isometric view of the airflow member of the inhaler liquid reservoir structure according to FIGS. [Figure 4B] FIG. 4B is a cross-sectional view of the blower member shown in FIG. 4A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0078] Detailed Description The foregoing summary, as well as the following detailed description of certain embodiments of the present invention, will be better understood when read in conjunction with the appended drawings.

[0079] As used herein, elements described in the singular and preceded by the word "a" or "an" should be understood as not excluding a plurality of such elements, unless such exclusion is expressly stated. Furthermore, references to "one embodiment" of the invention are not intended to be interpreted as excluding the existence of additional embodiments that also incorporate the recited features. Moreover, unless expressly stated to the contrary, embodiments "including" or "having" an element or elements having a particular characteristic can include additional such elements that do not have that characteristic.

[0080] The present invention relates to an ultrasonic mist inhaler. Although the description of the present invention and the accompanying figures are directed to an embodiment of an electronic vaporization inhaler, other embodiments are envisioned, such as inhalers for hookah, flavored liquids, medicines, and herbal supplements. Furthermore, the device can be packaged to look like an object rather than a cigarette. For example, the device can resemble another smoking device, such as a pipe, a water pipe, a slide, or the like, or the device can resemble another non-smoking related object.

[0081] The ultrasonic mist inhaler is either disposable or reusable. The term "reusable" as used herein means that the energy storage device is rechargeable or replaceable, or that the liquid can be replenished either by refilling or by replacing the liquid reservoir structure. Alternatively, in some embodiments, the reusable electronic device is both rechargeable and can be replenished with liquid. First, the disposable embodiment will be described, and then the reusable embodiment will be described.

[0082] Traditional electronic vaporizer inhalers tend to rely on inducing high temperatures in metal parts that are configured to heat the liquid in the inhaler, thus vaporizing the liquid that can be inhaled. The liquid typically contains nicotine and flavorings blended in a solution of propylene glycol (PG) and vegetable glycerin (VG), which are vaporized via the heating parts at high temperatures. Problems with traditional inhalers include the possibility of the metal burning, which can then be inhaled along with the burnt liquid. Also, some people do not like the burnt smell or taste of the heated liquid.

[0083] In contrast, the embodiments of the present disclosure include an ultrasonic mist inhaler that uses ultrasonic vibrations to turn liquid into mist, which creates microbubbles in the liquid. When these bubbles come into contact with surrounding air molecules, water droplets of about 0.25 to 0.5 microns are sprayed into the air, generating microdroplets that can be absorbed by breathing in the same way as inhaling mist.

[0084] Since no heating element is used, the heating element does not burn and the effects of sidestream smoke can be reduced.

[0085] FIG. 1 illustrates a disposable ultrasonic mist inhaler embodiment 100 of the present invention. As can be seen from FIG. 1, the ultrasonic mist inhaler 100 has a cylindrical body with a relatively long length compared to its diameter. In terms of shape and appearance, the ultrasonic mist inhaler 100 is designed to mimic the appearance of a typical cigarette. For example, the inhaler may comprise a first portion 101 that primarily mimics the tobacco rod portion of a cigarette, and a second portion 102 that primarily mimics the filter. In the disposable embodiment of the inventive device, the first portion and the second portion are a single, but separable, region of the device. The designations first portion 101 and second portion 102 are used for convenience to distinguish the components primarily contained in each portion.

[0086] 1, the ultrasonic mist inhaler is composed of a mouthpiece 1, a liquid reservoir structure 2, and a casing 3. A first part 101 constitutes the casing 3, and a second part 102 constitutes the mouthpiece 1 and the reservoir structure 2.

[0087] The first portion 101 contains the source energy.

[0088] The power storage device 30 provides power to the ultrasonic mist inhaler 100. The power storage device 30 can be, but is not limited to, a battery, such as a lithium ion battery, an alkaline battery, a zinc-carbon battery, a nickel-metal hydride battery, a nickel-cadmium battery, a supercapacitor, or a combination thereof. In a disposable embodiment, the electrical storage device 30 is not rechargeable, but in a reusable embodiment, the electrical storage device 30 will be selected to be rechargeable. In a disposable embodiment, the electrical storage device 30 is primarily selected to provide a constant voltage over the life of the inhaler 100. Otherwise, the performance of the inhaler will deteriorate over time. Preferred electrical storage devices that can provide a constant voltage output over the life of the device include lithium ion batteries and lithium polymer batteries.

[0089] The electrical storage device 30 has a first end 30a, which generally corresponds to a positive terminal, and a second end 30b, which generally corresponds to a negative terminal. The negative terminal extends to the first end 30a.

[0090] Because the electrical storage device 30 is located in the first part 101 and the liquid reservoir structure 2 is located in the second part 102, a joint is necessary to provide electrical communication between those components. In the present invention, the electrical communication is established using at least electrodes or probes that are compressed together when the first part 101 is clamped to the second part 102.

[0091] In this embodiment, the power storage device is rechargeable so that it can be reused. The casing 3 is provided with a charging port 32.

[0092] The integrated circuit 4 has a proximal end 4a and a distal end 4b. A positive terminal at the first end 30a of the electrical storage device 30 is in electrical communication with the positive lead of the flexible integrated circuit 4. A negative terminal at the second end 30b of the electrical storage device 30 is in electrical communication with the negative lead of the integrated circuit 4. The distal end 4b of the integrated circuit 4 is configured to include a microprocessor. The microprocessor is configured to process data from the sensor, control the lights, and direct the ultrasonic vibrations 5 in the second portion 102 to flow current and terminate the flow of current after a preprogrammed time.

[0093] The sensor detects when the ultrasonic mist inhaler 100 is being used (when a user inhales into the inhaler) and activates the microprocessor. The sensor can be selected to detect changes in pressure, airflow, or vibration. In a preferred embodiment, the sensor is a pressure sensor. In a digital embodiment, the sensor 30 takes continuous readings, and as a result, although a digital sensor must continuously draw current, the amount is small and the overall battery life will be negligibly affected.

[0094] Furthermore, the integrated circuit 4 may constitute an H-bridge, which may preferentially be formed by four MOSFETs, for converting direct current to alternating current at high frequency.

[0095] 2 and 3, there is shown an illustration of a liquid reservoir structure 2 according to an embodiment. The liquid reservoir structure 2 comprises a liquid chamber 21 adapted to receive the liquid to be atomized and an ultrasonic treatment chamber 22 in fluid communication with the liquid chamber 21.

[0096] In the embodiment shown, the liquid reservoir structure 2 comprises an intake channel 20 that provides an air passage from the sonication chamber 22 to the surroundings.

[0097] As an example of a sensor location, a sensor may be located in the ultrasonic treatment chamber 22.

[0098] The intake channel 20 has a frusto-conical element 20a and an inner container 20b.

[0099] As depicted in Figures 4A and 4B, the intake channel 20 further includes an air flow member 27 for providing air flow from the surroundings to the sonication chamber 22.

[0100] The airflow member 27 has an integral airflow bridge 27a and an airflow duct 27b, the airflow bridge 27a having two airway openings 27a' which form part of the intake channel 20, and the airflow duct 27b extending from the airflow bridge 27a into the ultrasonic treatment chamber 22 to provide airflow from the surroundings to the ultrasonic treatment chamber.

[0101] The airflow bridge 27a cooperates with the frusto-conical element 20a at the second diameter 25, 20a2.

[0102] The airflow bridge 27a has two opposing peripheral openings 27a'' that feed airflow into the airflow duct 27b.

[0103] The cooperation of the airflow bridge 27a with the frusto-conical element 20a is arranged such that two opposing peripheral openings 27a'' cooperate with complementary openings 20a'' of the frusto-conical element 20a.

[0104] The nozzle 1 and the frusto-conical element 20a are radially spaced apart with an airflow chamber 28 disposed therebetween.

[0105] As depicted in Figures 1 and 2, the mouthpiece 1 has two opposing peripheral openings 1''.

[0106] The peripheral openings 27 a ″, 20 a ″, 1 ″ of the airflow bridge 27 a, the frusto-conical element 20 a and the mouthpiece 1 provide maximum airflow directly to the ultrasonic treatment chamber 22 .

[0107] The frusto-conical element 20a includes an internal passage aligned in a similar direction as the suction channel 20, and has an internal passage such that the first diameter 20al is smaller than that of the second diameter 20a2, and the internal passage decreases in diameter across the frusto-conical element 20a.

[0108] The frustoconical element 20a is arranged in alignment with the means of ultrasonic vibration 5 and the capillary element 7, with a first diameter 20a1 communicating with the internal duct 11 of the mouthpiece 1 and a second diameter 20a2 communicating with the internal container 20b.

[0109] The inner container 20b has an inner wall that separates the ultrasonic treatment chamber 22 and the liquid chamber 21.

[0110] The liquid reservoir structure 2 has an outer container 20 c that defines the outer wall of a liquid chamber 21 .

[0111] The inner container 20b and the outer container 20c are the inner and outer walls of the liquid chamber 21, respectively.

[0112] The liquid reservoir structure 2 is disposed between the base 1 and the casing 3 and is detachable from the base 1 and the casing 3.

[0113] The liquid reservoir structure 2 and the mouthpiece 1 or casing 3 may include complementary arrangements for engaging with each other; further, such complementary arrangements may include any of a bayonet-type arrangement; a threaded engagement arrangement; a magnetic arrangement; or a friction fit arrangement, where the liquid reservoir structure 2 includes a portion of the arrangement and the mouthpiece 1 or casing 3 includes a complementary portion of the arrangement.

[0114] In the reusable embodiment, the components are substantially the same. The difference between the reusable embodiment versus the disposable embodiment is the accommodation made for replacing the liquid reservoir structure 2.

[0115] As shown in FIG. 3, the liquid chamber 21 has a top wall 23 and a bottom wall 25 which close the inner and outer vessels 20b and 20c of the liquid chamber 21.

[0116] The capillary element 7 is disposed between the first portion 20bl and the second portion 20b2 of the inner container 20b.

[0117] The capillary element 7 has a flat shape that extends from the sonication chamber to the liquid chamber.

[0118] As depicted in FIG. 2 or FIG. 3, the capillary element 7 is composed of a U-shaped central portion 7a and an L-shaped peripheral portion 7b.

[0119] The L-shaped portion 7b extends along the bottom wall 25 into the liquid chamber 21 above the inner container 20b.

[0120] The U-shaped portion 7a is housed within the ultrasonic treatment chamber 21. The U-shaped portion 7a is provided along the bottom wall 25 on the inner container 20b.

[0121] In the ultrasonic mist inhaler, the U-shaped portion 7a has an inner portion 7a1 and an outer portion 7a2, the inner portion 7a1 being in surface contact with the mist generating surface 50 of the ultrasonic vibration means 5, and the outer portion 7a2 not being in surface contact with the ultrasonic vibration means 5.

[0122] The bottom wall 25 of the liquid chamber 21 is a bottom plate 25 that closes the liquid chamber 21 and the ultrasonic treatment chamber 22. The bottom plate 25 is sealed, so that leakage of liquid from the ultrasonic treatment chamber 22 to the casing 3 is prevented.

[0123] The bottom plate 25 has an upper surface 25a having a recess 25b into which the elastic member 8 is inserted. The ultrasonic vibration means 5 is supported by the elastic member 8. The elastic member 8 is made of an annular plate-like rubber having an inner hole 8' in which a groove for supporting the ultrasonic vibration means 5 is designed.

[0124] The top wall 23 of the liquid chamber 21 is a cap 23 that closes the liquid chamber 23. The top wall 23 has an upper surface 23 that represents the maximum level of liquid that the liquid chamber 21 can contain, and a lower surface 25 that represents the minimum level of liquid in the liquid chamber 21.

[0125] Since the top wall 23 is sealed, leakage of liquid from the liquid chamber 21 to the ferrule 1 is prevented.

[0126] The top wall 23 and bottom wall 25 are secured to the liquid reservoir structure 2 by fastening means such as screws, adhesive, friction or the like.

[0127] As shown in Fig. 3, the elastic member is in line contact with the ultrasonic vibration means 5, and by preventing the ultrasonic vibration means 5 from contacting the wall of the inhaler, the vibration of the liquid reservoir structure is more effectively prevented from being inhibited, and thus the fine particles of the liquid atomized by the atomizing member can be sprayed farther.

[0128] As depicted in FIG. 3, the inner container 20b has an opening 20b' between the first portion 20bl and the second portion 20b2 through which the capillary element 7 extends from the sonication chamber 21. The capillary element 7 absorbs liquid from the liquid chamber 21 through the opening 20b'. The capillary element 7 is a wick 20. The capillary element 7 transports the liquid to the sonication chamber 22 by capillary action. The capillary element 7 is preferably made of bamboo fiber, although cotton, paper, or other fiber strands can be used for the wick material.

[0129] In one embodiment of the ultrasonic mist inhaler 100, as can be seen in FIG. 3, the means of ultrasonic vibration 5 is placed directly below the capillary element 7.

[0130] The means of ultrasonic vibration 5 may be a transducer. For example, the means of ultrasonic vibration 5 may be a piezoelectric transducer, preferably designed in the form of a circular plate. The material of the piezoelectric transducer is preferably ceramic.

[0131] Additionally, the means for ultrasonic vibration 5 can use a variety of transducer materials.

[0132] The end of the air duct 27bl faces the means of ultrasonic vibration 5. The means of ultrasonic vibration 5 is in electrical communication with the electrical contactors 101a, 101b. It is noteworthy that the distal end 4b of the integrated circuit 4 has an inner electrode and an outer electrode. The inner electrode contacts the first electrical contact 101a, which is a spring contact probe, and the outer electrode contacts the second electrical contact 101b, which is a side pin. Through the integrated circuit 4, the first electrical contact 101a is in electrical communication with the positive terminal of the storage device 30 by the microprocessor, and the second electrical contact 101b is in electrical communication with the negative terminal of the storage device 30.

[0133] The electrical contacts 101a, 101b traverse the base plate 25. The base plate 25 is adapted to be received inside the peripheral wall 26 of the liquid reservoir structure 2. The base plate 25 rests on complementary ridges, thereby forming the liquid chamber 21 and the sonication chamber 22.

[0134] The inner container 20b is constructed with a circular inner slot 20d into which a mechanical spring is applied.

[0135] By pressing the central portion 7a1 against the means of ultrasonic vibration 5, a mechanical spring 9 ensures a contact surface between them.

[0136] The liquid reservoir structure 2 and the base plate 25 can be made using a variety of thermoplastic materials.

[0137] When the user inhales on the ultrasonic mist inhaler 100, the airflow is sucked in through the peripheral opening 1″, passes through the airflow chamber 28, passes through the peripheral opening 27a″ of the airflow bridge 27a and the truncated cone element 20a, and flows down through the airflow duct 27b into the ultrasonic treatment chamber 22 and directly onto the capillary element 7. At the same time, liquid is sucked by capillary action from the reservoir chamber 21 through the multiple openings 20b′ into the capillary element 7. The capillary element 7 brings the liquid into contact with the ultrasonic vibration means 5 of the inhaler 100. In addition, the user's inhalation causes the pressure sensor to activate the integrated circuit 4, which then conducts a current to the ultrasonic vibration means 5. Thus, when the user draws on the mouthpiece 1 of the inhaler 100, two actions occur simultaneously. First, the sensor activates the integrated circuit 4, which triggers the ultrasonic vibration means 5 to start vibrating. Second, the trigger reduces the pressure outside the reservoir chamber 21 so that liquid begins to flow through the opening 20b', which saturates the capillary element 7. The capillary element 7 transports the liquid to the means of ultrasonic vibration 5, which causes bubbles to form in the capillary passage, atomizing the liquid. The atomized liquid is then inhaled by the user.

[0138] The ultrasonic mist inhaler 100 of the present disclosure is a more powerful version of current portable medical nebulizers, with a specific structure for effective vaporization in the shape and size of current e-cigarettes, providing a healthier alternative to cigarettes and current e-cigarette products.

[0139] The ultrasonic mist inhaler 100 of the present disclosure is particularly applicable to those who use electronic inhalers as a means of smoking cessation and reducing nicotine addiction. The ultrasonic mist inhaler 100 provides a method for gradually tapering the dosage of nicotine.

[0140] Other embodiments of the ultrasonic mist inhaler 100 of the present invention are readily envisioned, including drug delivery devices.

[0141] It is to be understood that the above description is illustrative and not restrictive. For example, the above-described embodiments can be used in combination with each other. In addition, many modifications can be made to adapt a particular situation or material to the teachings of the invention without departing from its scope.

Claims

1. An ultrasonic mist inhaler, a mouthpiece for inhaling the mist; a liquid reservoir structure comprising a liquid chamber adapted to receive the liquid to be misted; an ultrasonic treatment chamber in fluid communication with said liquid chamber, the ultrasonic treatment chamber comprising a means of ultrasonic vibration; a capillary element arranged between the liquid chamber and the ultrasonic treatment chamber, An ultrasonic mist inhaler, characterized in that at least a portion of the liquid reservoir structure and the mouthpiece form the ultrasonic treatment chamber, the capillary element comprises a central portion and a peripheral portion, the peripheral portion having an L-shaped cross-section extending to the liquid chamber, the central portion having a U-shaped cross-section extending to the ultrasonic treatment chamber, the U-shaped cross-section having an inner portion facing the inside of the ultrasonic mist inhaler and an outer portion facing the outside of the ultrasonic mist inhaler, the inner portion of the U-shaped cross-section being in surface contact with the ultrasonic vibration means, and the outer portion of the U-shaped cross-section not in surface contact with the ultrasonic vibration means.

2. 2. The ultrasonic mist inhaler of claim 1, further comprising an inhalation channel comprising a frusto-conical element disposed between the mouthpiece and the liquid reservoir structure.

3. 3. The ultrasonic mist inhaler of claim 2, wherein the inhalation channel comprises an internal container separating the sonication chamber and the liquid chamber.

4. 4. The ultrasonic mist inhaler of claim 3, wherein the inner container forms an inner wall of the liquid chamber.

5. 5. The ultrasonic mist inhaler of claim 4, wherein the mouthpiece comprises an internal duct for receiving the frusto-conical element.

6. 6. The ultrasonic mist inhaler according to claim 3, wherein the internal container comprises a first section and a second section in which the capillary element is disposed.

7. 7. The ultrasonic mist inhaler of claim 6, wherein the capillary element has a flat shape extending from the ultrasonic treatment chamber to the liquid chamber.

8. 8. The ultrasonic mist inhaler according to claim 7, wherein said ultrasonic vibration means is supported by an elastic member.

9. The ultrasonic mist inhaler according to any one of claims 1 to 8, characterized in that the liquid received in the liquid chamber comprises 57-70% (w / w) vegetable glycerin and 30-43% (w / w) propylene glycol, the propylene glycol containing nicotine and flavoring.

Citation Information

Patent Citations

  • Atomizer and electronic cigarette

    CN208837110U

  • Ultrasonic e-cigarette atomizer

    JP2019528724A

  • Diagonal ultrasonic atomization sheet structure, atomizer, and electronic cigarette

    JP2019535261A

  • Atomizers and electronic cigarettes

    JP2021535745A

  • Vaporizer cartridge

    WO2018111843A1